LakePharma announced that their GMP biorepository facility is now commercially operational at their Hopkinton, MA location, which is in close proximity to the Cambridge and Boston areas.

The GMP biorepository facility is a part of LakePharma’s GMP microBiomanufacturing Center, which began operations last month and is currently producing GMP-grade plasmid DNA. The GMP biorepository facility is dedicated to storing drug developers’ materials in various temperature conditions ranging from -135°C to 8°C, with state-of-the-art temperature alarm monitoring, secured keycard access, and comprehensive emergency recovery procedures. 

“The introduction of our GMP biorepository complements our GMP manufacturing services and furthers our ability to offer an end-to-end client solution. The market demand for cGMP services continues to expand, and LakePharma expects to participate in that growth.  We will scale our manufacturing capabilities and plan on hiring an additional 50 staff this year,” said Hua Tu, chief executive officer, LakePharma.